A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
Shah
M B
MB
Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, OH 45267-0714, USA.
Martin
J E
JE
Schroeder
T J
TJ
First
M R
MR
D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D012449:Safety
D007166:Immunosuppressive Agents; D016572:Cyclosporine